Highlights From San Francisco: The Evolving Role of The Radiation Oncologist in Lower-Grade Glioma Care

<p><span lang="EN-US" style= "font-size: 11.0pt; line-height: 115%; font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: 'Times New Roman'; mso-bidi-theme-font: minor-bidi; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;" xml:lang="EN-US">How might the advent of IDH inhibitors impact the practice of radiation oncologists and their role within the wider multidisciplinary team?</span><br /> <br /> Credit available for this activity expires: 11/20/2026<br /> Earn Credit / Learning Objectives & Disclosures: <a href= "https://www.medscape.org/viewarticle/highlights-san-francisco-evolving-role-radiation-oncologist-2025a1000uyk?ecd=bdc_podcast_libsyn_mscpedu"> https://www.medscape.org/viewarticle/highlights-san-francisco-evolving-role-radiation-oncologist-2025a1000uyk?ecd=bdc_podcast_libsyn_mscpedu</a></p>